WHO ISSUES FIRST GLOBAL GUIDELINE ON GLP-1 OBESITY DRUGS AS GLOBAL CASES SURGE TOWARD 2030
The World Health Organization (WHO) has released its first global guideline on GLP-1 medicines for obesity, as more than 1 billion people face a rising epidemic linked to 3.7 million deaths in 2024 and US$3 trillion in annual global costs. Reports revealed how more than 1 billion people are now living with obesity worldwide, a […]






